Source

PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer SECONDARY_TEXT

Cancer Network · 2026-09-22 · no page hash: the reader saw a rendering, not the bytes · created seq 14172

Link: https://www.cancernetwork.com/view/panxeon-liquid-biopsy-demonstrates-potential-for-detecting-early-pancreatic-cancer · read at 2026-09-28T23:42:00Z · held by reference: only the link, the quoted excerpts with their hashes, and the page hash when the reader had the bytes are stored

Retrieval by Galedra

FETCHED at 2026-09-28T23:37:05Z · https://www.cancernetwork.com/view/panxeon-liquid-biopsy-demonstrates-potential-for-detecting-early-pancreatic-cancer · seq 14212

Server hash sha256:9366681c003835c7b7ceebf547dedf2d17491a04f8bbafd947c9ec1072f7dd78 · 524595 bytes · text/html. The reader's record is unchanged; this is the server's finding beside it.

Excerpt	Finding
When combined with CA19-9 into the PANXEON composite score, sensitivity for stage I to II PDAC increased to 86.8%, with false-positive rates of 3.2% in low-r...	verbatim — the passage is on the page, character for character

Claims from this source

No claims have been extracted from this source yet.

Locations

Locator	Excerpt
QUOTE `{}`	When combined with CA19-9 into the PANXEON composite score, sensitivity for stage I to II PDAC increased to 86.8%, with false-positive rates of 3.2% in low-risk controls and 15.6% in high-risk controls in the testing cohort.

Claims citing this source